|
US5238808A
(en)
|
1984-10-31 |
1993-08-24 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
JPH066054B2
(ja)
|
1987-10-15 |
1994-01-26 |
帝人株式会社 |
動物細胞の培養方法
|
|
US5670373A
(en)
|
1988-01-22 |
1997-09-23 |
Kishimoto; Tadamitsu |
Antibody to human interleukin-6 receptor
|
|
US6428979B1
(en)
|
1988-01-22 |
2002-08-06 |
Tadamitsu Kishimoto |
Receptor protein for human B cell stimulatory factor-2
|
|
CA1341152C
(en)
|
1988-01-22 |
2000-12-12 |
Tadamitsu Kishimoto |
Receptor protein for human b cell stimulatory factor-2
|
|
US5068088A
(en)
|
1988-11-03 |
1991-11-26 |
Igen, Inc. |
Method and apparatus for conducting electrochemiluminescent measurements
|
|
ZA898290B
(en)
|
1988-11-03 |
1991-06-26 |
Igen Inc |
Electrochemiluminescent assays
|
|
KR0132666B1
(en)
|
1989-03-14 |
1998-04-14 |
Hitachi Kk |
Method for controlling cultivation conditions for animal cells
|
|
ES2093017T3
(es)
|
1989-07-20 |
1996-12-16 |
Tadamitsu Kishimoto |
Anticuerpo contra el receptor de la interleuquina-6 humana.
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
IL100866A
(en)
|
1991-02-06 |
1995-10-31 |
Igen Inc |
Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
|
|
US5795965A
(en)
|
1991-04-25 |
1998-08-18 |
Chugai Seiyaku Kabushiki Kaisha |
Reshaped human to human interleukin-6 receptor
|
|
US5821121A
(en)
|
1991-06-24 |
1998-10-13 |
Pacific Biomedical Research, Inc. |
Hormone-secreting cells maintained in long-term culture
|
|
JPH08508875A
(ja)
|
1992-05-01 |
1996-09-24 |
帝人株式会社 |
蛋白分泌細胞の流加回分培養法
|
|
EP0567738A3
(en)
|
1992-05-01 |
1995-09-06 |
American Cyanamid Co |
Controlling perfusion rates in continuous bioreactor culture of animal cells
|
|
US5888510A
(en)
|
1993-07-21 |
1999-03-30 |
Chugai Seiyaku Kabushiki Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
|
US20030108545A1
(en)
|
1994-02-10 |
2003-06-12 |
Patricia Rockwell |
Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
|
|
JPH07258252A
(ja)
|
1994-03-16 |
1995-10-09 |
Meiji Seika Kaisha Ltd |
チアゾール化合物およびその塩
|
|
US8017121B2
(en)
|
1994-06-30 |
2011-09-13 |
Chugai Seiyaku Kabushika Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
|
JP3630453B2
(ja)
|
1994-09-30 |
2005-03-16 |
中外製薬株式会社 |
Ｉｌ−６レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
|
|
CN1306963C
(zh)
|
1994-10-21 |
2007-03-28 |
岸本忠三 |
用于治疗il－6产生所致疾病的药物组合物
|
|
EP0800829B2
(en)
|
1994-12-29 |
2012-07-25 |
Chugai Seiyaku Kabushiki Kaisha |
Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin
|
|
EP0811384B1
(en)
|
1995-02-13 |
2006-06-21 |
Chugai Seiyaku Kabushiki Kaisha |
Muscle protein decomposition inhibitor containing il-6 receptor antibody
|
|
US5614191A
(en)
|
1995-03-15 |
1997-03-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
|
US5705364A
(en)
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
|
JP4224135B2
(ja)
|
1995-10-23 |
2009-02-12 |
ズィナイス セラピューティックス ピーティーワイ．エルティーディー． |
新規なヘモポエチン受容体およびそれをコードする遺伝子配列
|
|
US6087129A
(en)
|
1996-01-19 |
2000-07-11 |
Betagene, Inc. |
Recombinant expression of proteins from secretory cell lines
|
|
US6692742B1
(en)
|
1996-06-27 |
2004-02-17 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for myeloma to be used together with nitrogen mustard antitumor agents
|
|
WO1998041611A1
(en)
|
1997-03-20 |
1998-09-24 |
Regents Of The University Of Minnesota |
Process for the continuous culture of cells
|
|
EP2322216A1
(en)
|
1997-03-21 |
2011-05-18 |
Chugai Seiyaku Kabushiki Kaisha |
A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient
|
|
US20020187150A1
(en)
|
1997-08-15 |
2002-12-12 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient
|
|
CN100374159C
(zh)
|
1998-03-17 |
2008-03-12 |
中外制药株式会社 |
一种包含il-6拮抗剂活性成分的炎性肠道疾病的预防或治疗剂
|
|
US6537782B1
(en)
|
1998-06-01 |
2003-03-25 |
Chugai Seiyaku Kabushiki Kaisha |
Media for culturing animal cells and process for producing protein by using the same
|
|
US6406909B1
(en)
|
1998-07-10 |
2002-06-18 |
Chugai Seiyaku Kabushiki Kaisha |
Serum-free medium for culturing animal cells
|
|
ES2276525T3
(es)
|
1998-08-24 |
2007-06-16 |
Chugai Seiyaku Kabushiki Kaisha |
Preventivos o remedios para la pancreatitis que contienen anticuerpos anti-receptor il-6 como ingrediente activo.
|
|
US6284453B1
(en)
|
1999-09-29 |
2001-09-04 |
Steven Anthony Siano |
Method for controlling fermentation growth and metabolism
|
|
AU2001271021A1
(en)
|
2000-07-05 |
2002-01-14 |
Japan As Represented By Secretary Of Osaka University |
Process for producing glycoprotein
|
|
JP4812228B2
(ja)
|
2000-08-10 |
2011-11-09 |
中外製薬株式会社 |
抗体含有溶液の凝集物生成または白濁抑制方法
|
|
JP5485489B2
(ja)
|
2000-08-11 |
2014-05-07 |
中外製薬株式会社 |
抗体含有安定化製剤
|
|
US8703126B2
(en)
|
2000-10-12 |
2014-04-22 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
AU2002213441B2
(en)
|
2000-10-12 |
2006-10-26 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
US20040242847A1
(en)
|
2000-10-20 |
2004-12-02 |
Naoshi Fukushima |
Degraded agonist antibody
|
|
PT1356073E
(pt)
|
2000-10-20 |
2010-02-15 |
Bioneer As |
Método de fermentação aperfeiçoado para a produção de produtos genéticos heterólogos em bactérias do ácido láctico
|
|
CN1259973C
(zh)
|
2000-10-25 |
2006-06-21 |
中外制药株式会社 |
含有il－6拮抗剂作为有效成分的牛皮癣的预防或治疗剂
|
|
JP4889187B2
(ja)
|
2000-10-27 |
2012-03-07 |
中外製薬株式会社 |
Ｉｌ−６アンタゴニストを有効成分として含有する血中ｍｍｐ−３濃度低下剤
|
|
AU2000279624A1
(en)
|
2000-10-27 |
2002-05-15 |
Chugai Seiyaku Kabushiki Kaisha |
Blooe vegf level-lowering agent containing il-6 antagonist as the active ingredient
|
|
WO2002072615A1
(en)
|
2001-03-09 |
2002-09-19 |
Chugai Seiyaku Kabushiki Kaisha |
Method of purifying protein
|
|
AU2002256005A1
(en)
|
2001-03-27 |
2002-10-08 |
Smithkline Beecham Corporation |
Control of glycoforms in igg
|
|
UA80091C2
(en)
|
2001-04-02 |
2007-08-27 |
Chugai Pharmaceutical Co Ltd |
Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
|
|
AU2002316230A1
(en)
|
2001-06-13 |
2002-12-23 |
Genentech, Inc. |
Methods of culturing animal cells and polypeptide production in animal cells
|
|
CN101721362B
(zh)
|
2002-02-14 |
2018-07-03 |
中外制药株式会社 |
包含抗体的溶液制剂
|
|
CA2480059C
(en)
|
2002-03-22 |
2015-11-24 |
Amrad Operations Pty. Ltd. |
Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1)
|
|
JP3822137B2
(ja)
|
2002-05-20 |
2006-09-13 |
中外製薬株式会社 |
動物細胞培養用培地の添加剤およびそれを用いたタンパク質の製造方法
|
|
EP3225625A1
(en)
|
2002-09-11 |
2017-10-04 |
Chugai Seiyaku Kabushiki Kaisha |
Protein purification method
|
|
AU2003291254A1
(en)
|
2002-11-05 |
2004-06-07 |
Mount Sinai School Of Medicine Of New York University ; |
Ptpn11 (shp-2) mutations and cancer
|
|
DE10255508A1
(de)
|
2002-11-27 |
2004-06-17 |
Forschungszentrum Jülich GmbH |
Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
|
|
WO2004073741A1
(ja)
|
2003-02-24 |
2004-09-02 |
Chugai Seiyaku Kabushiki Kaisha |
インターロイキン－６アンタゴニストを含有する脊髄損傷治療剤
|
|
US20060239927A1
(en)
|
2003-03-31 |
2006-10-26 |
Kyowa Hakko Kogyo Co., |
Drug for airway administration
|
|
ES2383014T3
(es)
|
2003-04-02 |
2012-06-15 |
F. Hoffmann-La Roche Ag |
Anticuerpos contra el factor I de crecimiento similar a insulina y usos de los mismos
|
|
MXPA05010555A
(es)
|
2003-04-04 |
2006-03-09 |
Genentech Inc |
Formulaciones de proteina y anticuerpo de alta concentracion.
|
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
|
EP1623019B2
(en)
|
2003-05-15 |
2017-01-25 |
Wyeth LLC |
Restricted glucose feed for animal cell culture
|
|
AR046071A1
(es)
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
|
MXPA06003768A
(es)
|
2003-10-17 |
2006-06-23 |
Chugai Pharmaceutical Co Ltd |
Agente terapeutico para el mesotelioma.
|
|
AR048210A1
(es)
|
2003-12-19 |
2006-04-12 |
Chugai Pharmaceutical Co Ltd |
Un agente preventivo para la vasculitis.
|
|
AR048335A1
(es)
|
2004-03-24 |
2006-04-19 |
Chugai Pharmaceutical Co Ltd |
Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo
|
|
WO2005090405A1
(ja)
|
2004-03-24 |
2005-09-29 |
Chugai Seiyaku Kabushiki Kaisha |
インターロイキン－６受容体に対するヒト型化抗体のサブタイプ
|
|
TWI306862B
(en)
|
2005-01-03 |
2009-03-01 |
Hoffmann La Roche |
Antibodies against il-13 receptor alpha 1 and uses thereof
|
|
EP1835022B1
(en)
|
2005-01-05 |
2015-02-11 |
Chugai Seiyaku Kabushiki Kaisha |
Cell culture method and utilization of the same
|
|
WO2007043641A1
(ja)
|
2005-10-14 |
2007-04-19 |
Fukuoka University |
膵島移植における移植膵島障害抑制剤
|
|
AR058135A1
(es)
|
2005-10-21 |
2008-01-23 |
Chugai Pharmaceutical Co Ltd |
Agentes para el tratamiento de cardiopatias
|
|
AR057582A1
(es)
|
2005-11-15 |
2007-12-05 |
Nat Hospital Organization |
Agentes para suprimir la induccion de linfocitos t citotoxicos
|
|
TW200803894A
(en)
|
2005-11-25 |
2008-01-16 |
Univ Keio |
Prostate cancer therapeutic agents
|
|
WO2007074880A1
(ja)
|
2005-12-28 |
2007-07-05 |
Chugai Seiyaku Kabushiki Kaisha |
抗体含有安定化製剤
|
|
AU2007208678B2
(en)
|
2006-01-27 |
2013-01-10 |
Chugai Seiyaku Kabushiki Kaisha |
Therapeutic agents for diseases involving choroidal neovascularization
|
|
JP4902674B2
(ja)
|
2006-03-09 |
2012-03-21 |
エフ．ホフマン−ラ ロシュ アーゲー |
抗薬物抗体アッセイ法
|
|
JP5754875B2
(ja)
|
2006-04-07 |
2015-07-29 |
国立大学法人大阪大学 |
筋再生促進剤
|
|
JP5330829B2
(ja)
|
2006-08-04 |
2013-10-30 |
憲弘 西本 |
関節リウマチ患者の治療予後予測方法
|
|
TWI434855B
(zh)
|
2006-11-21 |
2014-04-21 |
Hoffmann La Roche |
結合物及其在免疫分析中作為參考標準之用途
|
|
JP2010095445A
(ja)
|
2006-12-27 |
2010-04-30 |
Tokyo Medical & Dental Univ |
Ｉｌ−６アンタゴニストを有効成分とする炎症性筋疾患治療剤
|
|
TWI438208B
(zh)
|
2007-01-23 |
2014-05-21 |
中外製藥股份有限公司 |
抑制慢性排斥反應之藥劑
|
|
EP2174667B1
(en)
|
2007-07-26 |
2017-01-04 |
Osaka University |
Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient
|
|
MX2010003329A
(es)
|
2007-09-26 |
2010-04-27 |
Chugai Pharmaceutical Co Ltd |
Anticuerpo anti-receptor de il-6.
|
|
RU2490025C2
(ru)
|
2007-10-02 |
2013-08-20 |
Чугаи Сейяку Кабусики Кайся |
Терапевтические средства, используемые против реакции трансплантат против хозяина, содержащие в качестве активного ингредиента ингибитор рецептора интерлейкина-6
|
|
SG185302A1
(en)
|
2007-10-15 |
2012-11-29 |
Chugai Pharmaceutical Co Ltd |
Method for production of antibody
|
|
CA2709127C
(en)
|
2007-12-15 |
2013-11-12 |
F. Hoffmann-La Roche Ag |
Distinguishing assay
|
|
PE20091174A1
(es)
|
2007-12-27 |
2009-08-03 |
Chugai Pharmaceutical Co Ltd |
Formulacion liquida con contenido de alta concentracion de anticuerpo
|
|
DE102008005523A1
(de)
|
2008-01-23 |
2009-07-30 |
Robert Bosch Gmbh |
Kraftstoffinjektor
|
|
JP2011512875A
(ja)
|
2008-03-11 |
2011-04-28 |
ジェネンテック， インコーポレイテッド |
増強されたａｄｃｃ機能を有する抗体
|
|
DE102008013899A1
(de)
|
2008-03-12 |
2009-09-17 |
F. Hoffmann-La Roche Ag |
Verfahren zur Herstellung rekombinanter Proteine bei konstantem Gehalt von pCO2 im Medium
|
|
CA2728243C
(en)
|
2008-06-05 |
2020-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Il-6 inhibitor for suppressing neuroinvasion in pancreatic cancer
|
|
US8323649B2
(en)
|
2008-11-25 |
2012-12-04 |
Alderbio Holdings Llc |
Antibodies to IL-6 and use thereof
|
|
WO2011013786A1
(ja)
|
2009-07-31 |
2011-02-03 |
Maeda Shin |
癌の転移抑制剤
|
|
US20110053223A1
(en)
|
2009-08-14 |
2011-03-03 |
Robert Bayer |
Cell culture methods to make antibodies with enhanced adcc function
|
|
SI2493922T1
(sl)
|
2009-10-26 |
2017-06-30 |
F. Hoffmann-La Roche Ag |
Postopek za proizvodnjo glikoziliranega imunoglobulina
|
|
WO2011128096A1
(en)
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
WO2011149046A1
(ja)
|
2010-05-28 |
2011-12-01 |
独立行政法人国立がん研究センター |
膵癌治療剤
|
|
WO2011149051A1
(ja)
|
2010-05-28 |
2011-12-01 |
中外製薬株式会社 |
抗腫瘍t細胞応答増強剤
|
|
CA2801107A1
(en)
|
2010-06-07 |
2011-12-15 |
F. Hoffman-La Roche Ag |
Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
KR20190120439A
(ko)
*
|
2010-11-08 |
2019-10-23 |
제넨테크, 인크. |
피하 투여용 항―ｉｌ―6 수용체 항체
|
|
HRP20250713T8
(hr)
|
2011-09-01 |
2025-10-24 |
Chugai Seiyaku Kabushiki Kaisha |
Postupak priprave pripravka koji sadrži visoko koncentrirana protutijela ultrafiltriranjem
|